GLP2T is a synthetic derivative of gastric inhibitory polypeptide (GIP) that has simultaneous glucagon-like peptide-1 (GLP-1) functionality as well. This combination allows GLP2T to lower blood glucose levels, increase insulin sensitivity, boost feelings of satiety. GLP2T was developed to fight type 2 diabetes, but has additionally been shown to protect the cardiovascular system. Research Use Only. Not For Human or Veterinary Use.